Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance

View ORCID ProfileJ.S. Copier, M. Bootsma, View ORCID ProfileC. Ng, A.A.M. Wilde, R.A. Bertels, H. Bikker, I. Christiaans, S.N. van der Crabben, J.A. Hol, T.T. Koopmann, J. Knijnenburg, A.A.J. Lommerse, J.J. van der Smagt, C.R. Bezzina, View ORCID ProfileJ.I. Vandenberg, A.O. Verkerk, D.Q.C.M. Barge-Schaapveld, View ORCID ProfileE.M. Lodder
doi: https://doi.org/10.1101/2022.08.05.502917
J.S. Copier
1Amsterdam UMC location University of Amsterdam, Experimental Cardiology, Meibergdreef 9, Amsterdam, The Netherlands
2Amsterdam Cardiovascular Sciences, Heart failure & arrhythmias, Amsterdam, The Netherlands
3Member of the European Reference Network for rare, low prevalence and complex diseases of the heart: ERN GUARD-Heart’ (ERN GUARDHEART; )
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J.S. Copier
  • For correspondence: j.s.copier@amsterdamumc.nl e.m.lodder@amsterdamumc.nl
M. Bootsma
4Leiden University Medical Center, Department of Cardiology, Albinusdreef 2, 2300 RC Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Ng
5Mark Cowley Lidwill Research Program in Cardiac Electrophysiology, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia
6School of Clinical Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Ng
A.A.M. Wilde
1Amsterdam UMC location University of Amsterdam, Experimental Cardiology, Meibergdreef 9, Amsterdam, The Netherlands
2Amsterdam Cardiovascular Sciences, Heart failure & arrhythmias, Amsterdam, The Netherlands
3Member of the European Reference Network for rare, low prevalence and complex diseases of the heart: ERN GUARD-Heart’ (ERN GUARDHEART; )
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.A. Bertels
7Leiden University Medical Center, Department of Paediatric Cardiology, Willem-Alexander Children’s Hospital, Albinusdreef 2, 2333 ZA, Leiden, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Bikker
3Member of the European Reference Network for rare, low prevalence and complex diseases of the heart: ERN GUARD-Heart’ (ERN GUARDHEART; )
8Amsterdam UMC location University of Amsterdam, Human Genetics, Meibergdreef 9, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Christiaans
9University Medical Centre Groningen, Department of Clinical Genetics, 9713GZ Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.N. van der Crabben
8Amsterdam UMC location University of Amsterdam, Human Genetics, Meibergdreef 9, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.A. Hol
10Erasmus MC, Clinical Genetics, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T.T. Koopmann
11Leiden University Medical Center, Clinical Genetics, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Knijnenburg
11Leiden University Medical Center, Clinical Genetics, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.A.J. Lommerse
4Leiden University Medical Center, Department of Cardiology, Albinusdreef 2, 2300 RC Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.J. van der Smagt
12University Medical Center Utrecht, Clinical Genetics, Lundlaan 6, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.R. Bezzina
1Amsterdam UMC location University of Amsterdam, Experimental Cardiology, Meibergdreef 9, Amsterdam, The Netherlands
2Amsterdam Cardiovascular Sciences, Heart failure & arrhythmias, Amsterdam, The Netherlands
3Member of the European Reference Network for rare, low prevalence and complex diseases of the heart: ERN GUARD-Heart’ (ERN GUARDHEART; )
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.I. Vandenberg
5Mark Cowley Lidwill Research Program in Cardiac Electrophysiology, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia
6School of Clinical Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J.I. Vandenberg
A.O. Verkerk
1Amsterdam UMC location University of Amsterdam, Experimental Cardiology, Meibergdreef 9, Amsterdam, The Netherlands
2Amsterdam Cardiovascular Sciences, Heart failure & arrhythmias, Amsterdam, The Netherlands
3Member of the European Reference Network for rare, low prevalence and complex diseases of the heart: ERN GUARD-Heart’ (ERN GUARDHEART; )
13Amsterdam UMC location University of Amsterdam, Medical Biology, Meibergdreef 9, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.Q.C.M. Barge-Schaapveld
11Leiden University Medical Center, Clinical Genetics, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E.M. Lodder
1Amsterdam UMC location University of Amsterdam, Experimental Cardiology, Meibergdreef 9, Amsterdam, The Netherlands
2Amsterdam Cardiovascular Sciences, Heart failure & arrhythmias, Amsterdam, The Netherlands
3Member of the European Reference Network for rare, low prevalence and complex diseases of the heart: ERN GUARD-Heart’ (ERN GUARDHEART; )
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E.M. Lodder
  • For correspondence: j.s.copier@amsterdamumc.nl e.m.lodder@amsterdamumc.nl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

ABSTRACT

Background Variants in KCNH2, encoding the hERG channel which is responsible for the rapid component of the cardiac delayed rectifier K+ current (IKr), are causal to Long QT Syndrome type 2 (LQTS2). We identified eight index patients with a new variant of unknown significance (VUS), KCNH2:c.2717C>T:p.(Ser906Leu). We aimed to elucidate the biophysiological effect of this variant, to enable reclassification and consequent clinical decision-making.

Methods A genotype-phenotype overview of the patients and relatives was created. The biophysiological effects were assessed by manual whole-cell patch-clamp using HEK293a cells expressing: (I) wild type (WT) KCNH2, (II) KCNH2-p.S906L alone (homozygous, Hm) or (III) KCNH2-p.S906L in combination with WT (1:1) (heterozygous, Hz). A calibrated automated patch-clamp assay using Flp-In HEK293 was used to follow up on the functional data.

Results Incomplete penetrance of LQTS2 in KCNH2:p.(Ser906Leu) carriers was observed. In addition, some patients were heterozygous for other VUSs in CACNA1C, PKP2, RYR2, or AKAP9. The phenotype of carriers of KCNH2:p.(Ser906Leu) ranged from asymptomatic to life-threatening arrhythmic events. Manual patch-clamp showed a reduced current density by 69.8%, and 60.4% in KCNH2-p.S906L-Hm and KCNH2-p.S906L-Hz, respectively. The time constant of activation was significantly increased with 80.1% in KCNH2-p.S906L-Hm compared to KCNH2-WT. Assessment of KCNH2-p.S906L-Hz, by calibrated automatic patch-clamp showed a reduction in current density by 35.6%.

Conclusion The reduced current density in the KCNH2-p.S906L-Hz indicates a moderate loss of function. Combined with the reduced penetrance and variable phenotype, we conclude that KCNH2:p.(Ser906Leu) is a low penetrant likely pathogenic variant for LQTS2.

Competing Interest Statement

A.A.M.W: consultant LQT therapeutics.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 05, 2022.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance
J.S. Copier, M. Bootsma, C. Ng, A.A.M. Wilde, R.A. Bertels, H. Bikker, I. Christiaans, S.N. van der Crabben, J.A. Hol, T.T. Koopmann, J. Knijnenburg, A.A.J. Lommerse, J.J. van der Smagt, C.R. Bezzina, J.I. Vandenberg, A.O. Verkerk, D.Q.C.M. Barge-Schaapveld, E.M. Lodder
bioRxiv 2022.08.05.502917; doi: https://doi.org/10.1101/2022.08.05.502917
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance
J.S. Copier, M. Bootsma, C. Ng, A.A.M. Wilde, R.A. Bertels, H. Bikker, I. Christiaans, S.N. van der Crabben, J.A. Hol, T.T. Koopmann, J. Knijnenburg, A.A.J. Lommerse, J.J. van der Smagt, C.R. Bezzina, J.I. Vandenberg, A.O. Verkerk, D.Q.C.M. Barge-Schaapveld, E.M. Lodder
bioRxiv 2022.08.05.502917; doi: https://doi.org/10.1101/2022.08.05.502917

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetics
Subject Areas
All Articles
  • Animal Behavior and Cognition (3691)
  • Biochemistry (7800)
  • Bioengineering (5678)
  • Bioinformatics (21295)
  • Biophysics (10584)
  • Cancer Biology (8179)
  • Cell Biology (11947)
  • Clinical Trials (138)
  • Developmental Biology (6764)
  • Ecology (10401)
  • Epidemiology (2065)
  • Evolutionary Biology (13874)
  • Genetics (9709)
  • Genomics (13074)
  • Immunology (8150)
  • Microbiology (20021)
  • Molecular Biology (7859)
  • Neuroscience (43072)
  • Paleontology (321)
  • Pathology (1279)
  • Pharmacology and Toxicology (2260)
  • Physiology (3353)
  • Plant Biology (7232)
  • Scientific Communication and Education (1314)
  • Synthetic Biology (2008)
  • Systems Biology (5539)
  • Zoology (1128)